Guaifenesin 65162-0037
Product NDC
65162-0037- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- July 27, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA207342
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 1200 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(3)
1 BOTTLE in 1 CARTON (65162-037-03) / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE
1 BOTTLE in 1 CARTON (65162-037-06) / 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
2 BLISTER PACK in 1 CARTON (65162-037-28) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK